We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:11-20 of 5,796

OIG Considers Drug Pricing History in an Unfavorable Advisory Opinion on Free Drugs
  • Holland & Knight LLP
  • USA
  • November 27 2018

The OIG issued an unfavorable Advisory Opinion on a proposed program by which a marketer would provide free drugs to hospitals to utilize in an

HRSA Proposes Advancing Implementation of 340B Penalties Rule
  • Manatt Phelps & Phillips LLP
  • USA
  • November 26 2018

On November 2, 2018, the federal Health Resources and Services Administration (HRSA) issued a proposed rule that would advance the implementation

OIG Disapproves of Drug Company’s Plan to Provide Hospitals Free Medications in Advisory Opinion
  • Robinson & Cole LLP
  • USA
  • November 26 2018

On November 16, 2018, the Office of the Inspector General of the Department of Health and Human Services (OIG) posted an unfavorable Advisory Opinion

FDA Loosens the Reins on Informed Consent Requirements for Certain Clinical Studies
  • Epstein Becker Green
  • USA
  • November 20 2018

Following up on its July 2017 guidance on the same topic (discussed in a previous blog post), FDA issued a proposed rule on November 15, 2018 to

A Review of U.S. Border Crossing Issues One Month After Cannabis Legalization
  • Blaney McMurtry LLP
  • USA, Canada
  • November 19 2018

On April 13, 2017, the Canadian Government introduced the Cannabis Act in the House of Commons. Its purpose was to legalize marijuana and establish a

New Proposed Medicare Part B Drug Reimbursement Model Raises Questions
  • Holland & Knight LLP
  • USA, United Kingdom
  • November 15 2018

The Centers for Medicare & Medicaid Services (CMS), part of the U.S. Department of Health and Human Services (HHS), announced a new proposed

Midterm Elections Place Healthcare Policy in Spotlight
  • Holland & Knight LLP
  • USA
  • November 12 2018

Healthcare was a top voter priority in the 2018 midterm elections, with 41 percent of national voters stating that healthcare was their "most

CMS Proposes Major Change to Medicare Part B Drug Payment System Introducing International Pricing Index Model
  • Hall Render Killian Heath & Lyman PC
  • USA
  • November 9 2018

The Centers for Medicare & Medicaid Services (“CMS”) Center for Medicare and Medicaid Innovation proposed to lower the cost of Medicare Part B

Mexico’s Supreme Court Strikes Prohibition on Private Consumption of Marijuana, Paving Way for Legalization
  • Duane Morris LLP
  • Mexico
  • November 9 2018

On October 31, 2018, the Supreme Court of Justice of Mexico (Suprema Corte de Justicia de la Nación) ruled in favor of two constitutional challenges

Supreme Court of Canada Bulletin
  • Gowling WLG
  • Canada
  • November 9 2018

Mr. Raîche, the applicant, is not represented by counsel. He instituted an action against the respondent, the Attorney General of Quebec, in 2015 for